ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $215,000 | -51.0% | 45,120 | -63.3% | 0.00% | – |
| Q4 2021 | $439,000 | +5.3% | 122,974 | +7.3% | 0.00% | – |
| Q3 2021 | $417,000 | +12.1% | 114,648 | +34.2% | 0.00% | – |
| Q2 2021 | $372,000 | +12.7% | 85,429 | +6.6% | 0.00% | – |
| Q1 2021 | $330,000 | +8.9% | 80,174 | +5.5% | 0.00% | – |
| Q4 2020 | $303,000 | +102.0% | 75,999 | +37.2% | 0.00% | – |
| Q3 2020 | $150,000 | +123.9% | 55,413 | +126.2% | 0.00% | – |
| Q2 2020 | $67,000 | -43.2% | 24,497 | -50.8% | 0.00% | – |
| Q1 2020 | $118,000 | -24.8% | 49,764 | +48.5% | 0.00% | – |
| Q4 2019 | $157,000 | +80.5% | 33,510 | +28.6% | 0.00% | – |
| Q3 2019 | $87,000 | – | 26,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |